Plain-English translation of NCT06347640 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different ways to regenerate the living tissue (pulp) inside a mature adult tooth that has died and developed an infection at the root tip. One approach uses your body's natural blood clot to trigger healing, while the other uses platelet-rich fibrin (PRF)—a concentrate made from your own blood that contains extra growth factors to stimulate tissue regrowth. Researchers believe regenerating the pulp might work better than traditional root canal treatment because it restores the tooth's natural blood supply and immune defenses.
While standard root canal treatment removes the dead pulp and fills the space, teeth treated this way are more likely to be lost over time because they lose their natural nerve and blood supply, plus their immune protection. This trial exists to see whether regenerating the pulp—rather than removing it—could give teeth a better chance of long-term survival and health.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the natural blood clot technique or the platelet-rich fibrin treatment to regenerate the pulp in your damaged tooth. The procedure involves carefully cleaning out the infected tissue, preparing the root canal space, and then placing either or the PRF material to stimulate new tissue growth. You would likely have follow-up appointments to monitor healing and ensure the tooth is responding well to the treatment.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
Jordan